Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival
Top Cited Papers
Open Access
- 7 November 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 36 (1), 76-81
- https://doi.org/10.1093/carcin/bgu227
Abstract
BRCA1-associated protein-1 (BAP1) mutations cause a new cancer syndrome, with a high rate of malignant mesothelioma (MM). Here, we tested the hypothesis that MM associated with germline BAP1 mutations has a better prognosis compared with sporadic MM. We compared survival among germline BAP1 mutation MM patients with that of all MM (N = 10 556) recorded in the United States Surveillance, Epidemiology, and End Results (SEER) data from 1973 to 2010. We identified 23 MM patients—11 alive—with germline BAP1 mutations and available data on survival. Ten patients had peritoneal MM, ten pleural MM and three MM in both locations. Thirteen patients had one or more malignancies in addition to MM. Actuarial median survival for the MM patients with germline BAP1 mutations was 5 years, as compared with BAP1 mutation MM showed that patients with peritoneal MM (median survival of 10 years, P = 0.0571), or with a second malignancy in addition to MM (median survival of 10 years, P = 0.0716), survived for a longer time compared with patients who only had pleural MM, or MM patients without a second malignancy, respectively. In conclusion, we found that MM patients with germline BAP1 mutations have an overall 7-fold increased long-term survival, independently of sex and age. Appropriate genetic counseling and clinical management should be considered for MM patients who are also BAP1 mutation carriers.Keywords
This publication has 51 references indexed in Scilit:
- A BAP1 Mutation in a Danish Family Predisposes to Uveal Melanoma and Other CancersPLOS ONE, 2013
- BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITsJournal of Translational Medicine, 2012
- Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma FamiliesPLOS ONE, 2012
- Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008Bulletin of the World Health Organization, 2011
- Germline BAP1 mutations predispose to malignant mesotheliomaNature Genetics, 2011
- Germline mutations in BAP1 predispose to melanocytic tumorsNature Genetics, 2011
- Malignant mesothelioma: Facts, Myths, and HypothesesJournal of Cellular Physiology, 2011
- Frequent Mutation of BAP1 in Metastasizing Uveal MelanomasScience, 2010
- Malignant Pleural Mesothelioma: A Population-Based Study of SurvivalJournal of Thoracic Oncology, 2010
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional ExperienceJournal of Clinical Oncology, 2009